KinergyCare is a Virginia-based startup and a Virginia Bio member that is requesting feedback from this community on a care coaching and coordination approach that focuses on the needs of patients with cardiovascular disease. We’re pioneering a new approach that combines patient data on health capabilities with a personalized intervention based on behavioral science. The result should be a more personalized clinical intervention and coaching approach that better ensures lasting behavioral change. We’re looking to talk with stakeholders such as cardiologists, nurses, care management teams, and administrators to learn more about the unmet needs. This outreach is part of our participation in the Spring cohort of the Roanoke Acceleration and Mentoring Program (RAMP), so we would really appreciate any help. Please help us by filling in this brief, 10 question survey. Also, if you have some guidance or can connect us with someone in your network that fits the above roles please contact KinergyCare CEO Art Spivy at aspivy@kinergycare.com or (571) 277-5373. Thanks for your help!
News
Recent News
10/13/2026
Virginia Western and Radford University sign 3 new agreements to create seamless transfer for medical laboratory science degree
Virginia Western Community College and Radford University celebrated a strengthened partnership on Monday, Oct. 12, that will enable seamless transfer for students in three health-related programs. Virginia Western President Laura J. Treanor and Radford President Bret Danilowicz signed the articulation agreements in a ceremony on the Virginia Western campus. Virginia Western students who meet all requirements and complete …
10/07/2026
Roanoke Lands $1 Million Federal Grant to Equip RoVa Labs Biotech Incubator
The Roanoke City Council has accepted a $1 million U.S. Small Business Administration grant to purchase advanced laboratory equipment for RoVa Labs, a biotechnology startup incubator that combines biomedical research facilities with business development support. Since opening in May 2026, RoVa Labs has grown to house nine research tenants, and officials say the new funding …
10/07/2026
Kaléo Awarded $96.1 Million BARDA Contract to Advance 2-PAM Auto-Injector for U.S. Chemical Threat Preparedness
Kaléo, a global leader in drug-delivery device technology and auto-injector innovation, today announced it has been awarded a Project BioShield contract by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS), to support the late-stage development, …